Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer

Published:2019-09-24 Issue:1 Volume:52 Page:77-85
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Fukuoka Kenichiro,Teishima Jun,Nagamatsu Hirotaka,Inoue Shogo,Hayashi Tetsutaro,Mita Koji,Shigeta Masanobu,Kobayashi Kanao,Kajiwara Mitsuru,Kadonishi Yuichi,Tacho Takatoshi,Matsubara Akio

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11255-019-02281-4.pdf

Reference32 articles.

1. Akaza H, Usami M, Hinotsu S et al (2004) Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. Jpn J Clin Oncol 34:329–336

2. Hussain M, Fizazi K, Saad F et al (2018) Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med 378:2465–2474

3. Smith MR, Saad F, Chowdhury S et al (2018) Apalutamide treatment and metastasis-free survival in prostate cancer. N Engl J Med 378:1408–1418

4. Mizokami A, Kadono Y, Kitagawa Y et al (2017) Therapies for castration-resistant prostate cancer in a new era: the indication of vintage hormonal therapy, chemotherapy and the new medicines. Int J Urol 24:566–572

5. European Association of Urology (EAU). Oncology Guidelines: Prostate Cancer, 2018. https://uroweb.org/guideline/prostate-cancer/ . Accessed 24 May 2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer;Scientific Reports;2022-09-28

2. Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer;In Vivo;2021

3. Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review;Cancer Cell International;2020-08-26